FDA warning letters question mouthwash claims

Sep 27, 2010

The FDA today issued warning letters to Johnson & Johnson, CVS, and Walgreen telling them to stop promoting certain mouthwash products with claims that they remove plaque above the gum line or promote healthy gums.

Click here to read the rest of the article.

Latest in Regulatory Updates
Fda Sign Dc
Hearing reveals end of fluoride supplements may be near
July 23, 2025
Discipline Employee
After 6 malpractice claims, dentist is sanctioned a 3rd time, once his license expires
July 17, 2025
$4.4M/year... working only 2 days a week? Discover how.
Sponsored
$4.4M/year... working only 2 days a week? Discover how.
July 25, 2025
Dr. Divya Mudumba.
Opinion: Why advocacy in dentistry matters
July 3, 2025
Related Stories
2009 07 28 13 33 39 581 Fda Logo 70
Regulatory Updates
FDA targets improvements to 510(k) process
2009 07 28 13 33 39 581 Fda Logo 70
Regulatory Updates
FDA advisory panel to review dental amalgam
2009 12 03 14 52 29 719 Smile 70
Regulatory Updates
ADA asks FDA to classify teeth-bleaching chemicals
$4.4M/year... working only 2 days a week? Discover how.
Sponsor Content
$4.4M/year... working only 2 days a week? Discover how.
More in Regulatory Updates
Hearing reveals end of fluoride supplements may be near
By Melissa Busch
The early hours of a U.S. Food and Drug Administration hearing held on July 23 to collect feedback on concerns associated with prescription fluoride supplements for kids reveal the future of the cavity-fighter may be in trouble.
July 23, 2025
Fda Sign Dc
After 6 malpractice claims, dentist is sanctioned a 3rd time, once his license expires
By Clark Kauffman
A former West Des Moines, IA, dentist who has been sued six times for medical malpractice has been sanctioned for the third time by the Iowa Dental Board.
July 17, 2025
Discipline Employee
Dentists say it’s time to stop handling anesthesia alone
By Melissa Busch
Dentists say it’s time for laws to change to make procedures involving anesthesia safer by requiring an anesthesiologist.
July 14, 2025
Dental Patient Anesthesia Luengo Ua
Opinion: Why advocacy in dentistry matters
By Dr. Divya Mudumba
For Dr. Divya Mudumba, participating in the Academy of General Dentistry’s Hill Day reminded her of the importance of advocacy for the profession.
July 3, 2025
Dr. Divya Mudumba.
FDA meeting set to discuss pulling fluoride supplements
By Melissa Busch
Here’s your chance to discuss the U.S. Food and Drug Administration (FDA) possibly pulling fluoride supplements for children from the market.
June 27, 2025
Fda Sign Dc
FDA OKs Cube Click's dental AI diagnostic
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Cube Click's artificial intelligence (AI)-powered diagnostic device Smile Dx.
June 24, 2025
Approved Stamp
VCS Medical's topical dental anesthetic gets FDA nod
By DrBicuspid.com staff writers
VCS Medical’s oral topical anesthetic spray DentalJect has received U.S. Food and Drug Administration (FDA) clearance.
June 23, 2025
Approved Stamp
FDA OKs Theodent's fluoride-free varnish
By DrBicuspid.com staff writers
Theodent has received U.S. Food and Drug Administration (FDA) clearance for its Rennou Varnish.
June 20, 2025
Approved Signature
CDA lauds delaying dental funding cuts
By DrBicuspid.com staff writers
The California Dental Association (CDA) supports the state legislature’s decision to delay Gov. Gavin Newsom’s proposal to cut Proposition 56 funding for Medi-Cal Dental and dental coverage for undocumented adults.
June 12, 2025
California Capitol Pablos
Pearl's Second Opinion 3D gets FDA nod
Dental artificial intelligence solutions provider Pearl has received U.S Food and Drug Administration (FDA) clearance for its Second Opinion 3D.
June 1, 2025
Fda Sign Dc
ADHA opposes bill, claiming it bypasses accreditation
By DrBicuspid.com staff writers
American Dental Hygienists’ Association (ADHA) President Erin Haley-Hitz has publicly opposed Nevada Senate Bill 495.
May 28, 2025
Hand Stop Sign 400
FDA aims to pull fluoride supplements from the market
By Melissa Busch
The U.S. Food and Drug Administration (FDA) announced on May 13 that it aims to remove concentrated ingestible fluoride prescription drops and tablets for infants and toddlers from the market.
May 13, 2025
Fda Sign Dc
Page 1 of 73
Next Page